High-throughput crystallography for lead discovery in drug design.
Knowledge of the three-dimensional structures of protein targets now emerging from genomic data has the potential to accelerate drug discovery greatly. X-ray crystallography is the most widely used technique for protein structure determination, but technical challenges and time constraints have traditionally limited its use primarily to lead optimization. Here, we describe how significant advances in process automation and informatics have aided the development of high-throughput X-ray crystallography, and discuss the use of this technique for structure-based lead discovery.
Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1GA, UK. tom@cryst.bioc.cam.ac.uk
Tom L
TL
Blundell
Harren
H
Jhoti
Chris
C
Abell
D003461:Crystallography; D015195:Drug Design; D004345:Drug Industry; D008024:Ligands
D008024:Ligands